GPR37 surface expression enhancement via N-terminal truncation or protein-protein interactions

Biochemistry

Volumn 48, Issue 43, 2009, Pages 10286-10297

  Dunham, Jill H ^a   Meyer, Rebecca C ^a   Garcia, Erin L ^a   Hall, Randy A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR; CELL SURFACES; CELL TYPES; CO-EXPRESSION; CO-IMMUNOPRECIPITATION EXPERIMENTS; COEXPRESSED; ENDOTHELIN; FUNCTIONAL ACTIVITIES; G-PROTEIN COUPLED RECEPTORS; HEK293 CELLS; HETEROLOGOUS CELLS; N-TERMINAL TRUNCATION; PLASMA MEMBRANES; PROTEIN-PROTEIN INTERACTIONS; SPECIFIC INTERACTION; SURFACE EXPRESSION; SYNTENIN;

AMINES; AMINO ACIDS; ORGANIC ACIDS; PLASMAS;

CELL MEMBRANES;

ADENOSINE A2 RECEPTOR; DOPAMINE RECEPTOR; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 37; MEMBRANE PROTEIN; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CELL MEMBRANE; CELL MIGRATION; CELL STRAIN HEK293; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE INSERTION SEQUENCE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; LIGAND BINDING; MATRIX ATTACHMENT REGION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

BLOTTING, WESTERN; CELL LINE; CELL MEMBRANE; DOPAMINE; FLOW CYTOMETRY; HALOPERIDOL; HUMANS; IMMUNOPRECIPITATION; MICROSCOPY, CONFOCAL; PROTEIN BINDING; QUINPIROLE; RECEPTORS, DOPAMINE D2; RECEPTORS, G-PROTEIN-COUPLED; SYNTENINS;

EID: 70350517456     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi9013775     Document Type: Article

References (54)

1. Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y., and Takahashi, R. (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 105, 891-902. (Pubitemid 32635090)
2. Zeng, Z., Su, K., Kyaw, H., and Li, Y. (1997) A novel endothelin receptor type-B-like gene enriched in the brain. Biochem. Biophys. Res. Commun. 233, 559-567.
3. Leng, N., Gu, G., Simerly, R. B., and Spindel, E. R. (1999) Molecular cloning and characterization of two putative G protein-coupled receptors which are highly expressed in the central nervous system. Brain Res. Mol. Brain Res. 69, 73-83.
4. Marazziti, D., Golini, E., Gallo, A., Lombardi, M. S., Matteoni, R., and Tocchini-Valentini, G. P. (1997) Cloning of GPR37, a gene located on chromosome 7 encoding a putative G-protein-coupled peptide receptor, from a human frontal brain EST library. Genomics 45, 68-77. (Pubitemid 27449385)
5. Valdenaire, O., Giller, T., Breu, V., Ardati, A., Schweizer, A., and Richards, J. G. (1998) A new family of orphan G protein-coupled receptors predominantly expressed in the brain. FEBS Lett. 424, 193-196. (Pubitemid 28135312)
6. Rezgaoui, M., Susens, U., Ignatov, A., Gelderblom, M., Glassmeier, G., Franke, I., Urny, J., Imai, Y., Takahashi, R., and Schaller, H. C. (2006) The neuropeptide head activator is a high-affinity ligand for the orphan G-protein-coupled receptor GPR37. J. Cell Sci. 119, 542-549.
7. Imai, Y., Soda, M., Hatakeyama, S., Akagi, T., Hashikawa, T., Nakayama, K. I., and Takahashi, R. (2002) CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol. Cell 10, 55-67. (Pubitemid 34876562)
8. Kubota, K., Niinuma, Y., Kaneko, M., Okuma, Y., Sugai, M., Omura, T., Uesugi, M., Uehara, T., Hosoi, T., and Nomura, Y. (2006) Suppressive effects of 4-phenylbutyrate on the aggregation of Pael receptors and endoplasmic reticulum stress. J. Neurochem. 97, 1259-1268. (Pubitemid 43725566)
9. Marazziti, D., Di Pietro, C., Golini, E., Mandillo, S., Matteoni, R., and Tocchini-Valentini, G. P. (2009) Induction of macroautophagy by overexpression of the Parkinson's disease-associated GPR37 receptor. FASEB J. 23, 1-10.
10. Marazziti, D., Golini, E., Mandillo, S., Magrelli, A., Witke, W., Matteoni, R., and Tocchini-Valentini, G. P. (2004) Altered dopamine signaling and MPTP resistance in mice lacking the Parkinson's disease-associated GPR37/parkin-associated endothelin-like receptor. Proc. Natl. Acad. Sci. U.S.A. 101, 10189-10194.
11. Couve, A., Filippov, A. K., Connolly, C. N., Bettler, B., Brown, D. A., and Moss, S. J. (1998) Intracellular retention of recombinant GABAB receptors. J. Biol. Chem. 273, 26361-26367.
12. Calver, A. R., Robbins, M. J., Cosio, C., Rice, S. Q., Babbs, A. J., Hirst, W. D., Boyfield, I., Wood, M. D., Russell, R. B., Price, G. W., Couve, A., Moss, S. J., and Pangalos, M. N. (2001) The C-terminal domains of the GABA(b) receptor subunits mediate intracellular trafficking but are not required for receptor signaling. J. Neurosci. 21, 1203-1210. (Pubitemid 32128765)
13. Margeta-Mitrovic, M., Jan, Y. N., and Jan, L. Y. (2000) A trafficking checkpoint controls GABA(B) receptor heterodimerization. Neuron 27, 97-106.
14. Margeta-Mitrovic, M., Mitrovic, I., Riley, R. C., Jan, L. Y., and Basbaum, A. I. (1999) Immunohistochemical localization of GABA- (B) receptors in the rat central nervous system. J. Comp. Neurol. 405, 299-321.
15. Pagano, A., Rovelli, G., Mosbacher, J., Lohmann, T., Duthey, B., Stauffer, D., Ristig, D., Schuler, V., Meigel, I., Lampert, C., Stein, T., Prezeau, L., Blahos, J., Pin, J., Froestl, W., Kuhn, R., Heid, J., Kaupmann, K., and Bettler, B. (2001) C-Terminal interaction is essential for surface trafficking but not for heteromeric assembly of GABA(b) receptors. J. Neurosci. 21, 1189-1202. (Pubitemid 32128764)
16. Andersson, H., D'Antona, A. M., Kendall, D. A., Von Heijne, G., and Chin, C. N. (2003) Membrane assembly of the cannabinoid receptor 1: Impact of a long N-terminal tail. Mol. Pharmacol. 64, 570-577.
17. Hague, C., Chen, Z., Pupo, A. S., Schulte, N. A., Toews, M. L., and Minneman, K. P. (2004) The N terminus of the human R1D-adrenergic receptor prevents cell surface expression. J. Pharmacol. Exp. Ther. 309, 388-397.
18. Hague, C., Uberti, M. A., Chen, Z., Hall, R. A., and Minneman, K. P. (2004) Cell surface expression of R1D-adrenergic receptors is controlled by heterodimerization with R1B-adrenergic receptors. J. Biol. Chem. 279, 15541-15549.
19. Pupo, A. S., Uberti, M. A., and Minneman, K. P. (2003) N-Terminal truncation of human R1D-adrenoceptors increases expression of binding sites but not protein. Eur. J. Pharmacol. 462, 1-8.
20. Uberti, M. A., Hall, R. A., and Minneman, K. P. (2003) Subtype-specific dimerization of R1-adrenoceptors: Effects on receptor expression and pharmacological properties. Mol. Pharmacol. 64, 1379-1390.
21. Dunham, J. H., and Hall, R. A. (2009) Enhancement of the surface expression of G protein-coupled receptors. Trends Biotechnol. 27, 541-545.
22. Prinster, S. C., Hague, C., and Hall, R. A. (2005) Heterodimerization of g protein-coupled receptors: Specificity and functional significance. Pharmacol. Rev. 57, 289-298.
23. Bulenger, S., Marullo, S., Chen, Z., and Bouvier, M. (2005) Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol. Sci. 26, 131-137.
24. Ferre, S., Quiroz, C., Woods, A. S., Cunha, R., Popoli, P., Ciruela, F., Lluis, C., Franco, R., Azdad, K., and Schiffmann, S. N. (2008) An update on adenosine A2A-dopamine D2 receptor interactions: Implications for the function of G protein-coupled receptors. Curr. Pharm. Des. 14, 1468-1474.
25. Milligan, G. (2009) G protein-coupled receptor hetero-dimerization: Contribution to pharmacology and function. Br. J. Pharmacol. 158, 5-14.
26. Weinman, E. J., Hall, R. A., Friedman, P. A., Liu-Chen, L. Y., and Shenolikar, S. (2006) The association of NHERF adaptor proteins with G protein-coupled receptors and receptor tyrosine kinases. Annu. Rev. Physiol. 68, 491-505.
27. Yang, Y., Nishimura, I., Imai, Y., Takahashi, R., and Lu, B. (2003) Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila. Neuron 37, 911-924. (Pubitemid 36398298)
28. Marazziti, D., Mandillo, S., Di Pietro, C., Golini, E., Matteoni, R., and Tocchini-Valentini, G. P. (2007) GPR37 associates with the dopamine transporter to modulate dopamine uptake and behavioral responses to dopaminergic drugs. Proc. Natl. Acad. Sci. U.S.A. 104, 9846-9851.
29. He, L., Fong, J., von Zastrow, M., and Whistler, J. L. (2002) Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell 108, 271-282. (Pubitemid 34161146)
30. Lavoie, C., Mercier, J. F., Salahpour, A., Umapathy, D., Breit, A., Villeneuve, L. R., Zhu, W. Z., Xiao, R. P., Lakatta, E. G., Bouvier, M., and Hebert, T. E. (2002) β1/β2-adrenergic receptor heterodimerization regulates β2-adrenergic receptor internalization and ERK signaling efficacy. J. Biol. Chem. 277, 35402-35410.
31. Uberti, M. A., Hague, C., Oller, H., Minneman, K. P., and Hall, R. A. (2005) Heterodimerization with β2-adrenergic receptors promotes surface expression and functional activity of R1D-adrenergic receptors. J. Pharmacol. Exp. Ther. 313, 16-23.
32. Fam, S. R., Paquet, M., Castleberry, A. M., Oller, H., Lee, C. J., Traynelis, S. F., Smith, Y., Yun, C. C., and Hall, R. A. (2005) P2Y1 receptor signaling is controlled by interaction with the PDZ scaffold NHERF-2. Proc. Natl. Acad. Sci. U.S.A. 102, 8042-8047.
33. He, J., Bellini, M., Inuzuka, H., Xu, J., Xiong, Y., Yang, X., Castleberry, A. M., and Hall, R. A. (2006) Proteomic analysis of β1-adrenergic receptor interactions with PDZ scaffold proteins. J. Biol. Chem. 281, 2820-2827.
34. Ohno, K., Koroll, M., El Far, O., Scholze, P., Gomeza, J., and Betz, H. (2004) The neuronal glycine transporter 2 interacts with the PDZ domain protein syntenin-1. Mol. Cell. Neurosci. 26, 518-529.
35. Armsen, W., Himmel, B., Betz, H., and Eulenburg, V. (2007) The C-terminal PDZ-ligand motif of the neuronal glycine transporter GlyT2 is required for efficient synaptic localization. Mol. Cell. Neurosci. 36, 369-380.
36. Nordstrom, R., and Andersson, H. (2006) Amino-terminal processing of the human cannabinoid receptor 1. J. Recept. Signal Transduction Res. 26, 259-267.
37. He, J., Xu, J., Castleberry, A. M., Lau, A. G., and Hall, R. A. (2002) Glycosylation of β1-adrenergic receptors regulates receptor surface expression and dimerization. Biochem. Biophys. Res. Commun. 297, 565-572.
38. Alken, M., Schmidt, A., Rutz, C., Furkert, J., Kleinau, G., Rosenthal, W., and Schulein, R. (2009) The sequence after the signal peptide of the G protein-coupled endothelin B receptor is required for efficient translocon gating at the endoplasmic reticulum membrane. Mol. Pharmacol. 75, 801-811.
39. Deslauriers, B., Ponce, C., Lombard, C., Larguier, R., Bonnafous, J. C., and Marie, J. (1999) N-Glycosylation requirements for the AT1a angiotensin II receptor delivery to the plasma membrane. Biochem. J. 339 (Part 2), 397-405. (Pubitemid 29209971)
40. Davis, D., Liu, X., and Segaloff, D. L. (1995) Identification of the sites of N-linked glycosylation on the follicle-stimulating hormone (FSH) receptor and assessment of their role in FSH receptor function. Mol. Endocrinol. 9, 159-170.
41. Klammt, C., Srivastava, A., Eifler, N., Junge, F., Beyermann, M., Schwarz, D., Michel, H., Doetsch, V., and Bernhard, F. (2007) Functional analysis of cell-free-produced human endothelin B receptor reveals transmembrane segment 1 as an essential area for ET-1 binding and homodimer formation. FEBS J. 274, 3257-3269. (Pubitemid 47024965)
42. Doi, T., Hiroaki, Y., Arimoto, I., Fujiyoshi, Y., Okamoto, T., Satoh, M., and Furuichi, Y. (1997) Characterization of human endothelin B receptor and mutant receptors expressed in insect cells. Eur. J. Biochem. 248, 139-148.
43. Bodenmuller, H., and Schaller, H. C. (1981) Conserved amino acid sequence of a neuropeptide, the head activator, from coelenterates to humans. Nature 293, 579-580.
44. Bodenmuller, H., Schaller, H. C., and Darai, G. (1980) Human hypothalamus and intestine contain a hydra-neuropeptide. Neurosci. Lett. 16, 71-74.
45. Ekman, R., Salford, L., Brun, A., and Larsson, I. (1990) Hydra head activator-like immunoreactivity in human brain astrocytomas grade III-IV and the surrounding brain tissue. Peptides 11, 271-275. (Pubitemid 20144895)
46. Fuxe, K., Ferre, S., Genedani, S., Franco, R., and Agnati, L. F. (2007) Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiol. Behav. 92, 210-217.
47. Lein, E. S., Hawrylycz, M. J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A. F., Boguski, M. S., Brockway, K. S., Byrnes, E. J., Chen, L., Chen, T. M., Chin, M. C., Chong, J., Crook, B. E., Czaplinska, A., Dang, C. N., Datta, S., Dee, N. R., Desaki, A. L., Desta, T., Diep, E., Dolbeare, T. A., Donelan, M. J., Dong, H. W., Dougherty, J. G., Duncan, B. J., Ebbert, A. J., Eichele, G., Estin, L. K., Faber, C., Facer, B. A., Fields, R., Fischer, S. R., Fliss, T. P., Frensley, C., Gates, S. N., Glattfelder, K. J., Halverson, K. R., Hart, M. R., Hohmann, J. G., Howell, M. P., Jeung, D. P., Johnson, R. A., Karr, P. T., Kawal, R., Kidney, J. M., Knapik, R. H., Kuan, C. L., Lake, J. H., Laramee, A. R., Larsen, K. D., Lau, C., Lemon, T. A., Liang, A. J., Liu, Y., Luong, L. T., Michaels, J., Morgan, J. J., Morgan, R. J., Mortrud, M. T., Mosqueda, N. F., Ng, L. L., Ng, R., Orta, G. J., Overly, C. C., Pak, T. H., Parry, S. E., Pathak, S. D., Pearson, O. C., Puchalski, R. B., Riley, Z. L., Rockett, H. R., Rowland, S. A., Royall, J. J., Ruiz, M. J., Sarno, N. R., Schaffnit, K., Shapovalova, N. V., Sivisay, T., Slaughterbeck, C. R., Smith, S. C., Smith, K. A., Smith, B. I., Sodt, A. J., Stewart, N. N., Stumpf, K. R., Sunkin, S. M., Sutram, M., Tam, A., Teemer, C. D., Thaller, C., Thompson, C. L., Varnam, L. R., Visel, A., Whitlock, R. M., Wohnoutka, P. E., Wolkey, C. K., Wong, V. Y., Wood, M., Yaylaoglu, M. B., Young, R. C., Youngstrom, B. L., Yuan, X. F., Zhang, B., Zwingman, T. A., and Jones, A. R. (2007) Genome-wide atlas of gene expression in the adult mouse brain. Nature 445, 168-176. (Pubitemid 46095716)
48. Strange, P. G. (2008) Antipsychotic drug action: Antagonism, inverse agonism or partial agonism. Trends Pharmacol. Sci. 29, 314-321.
49. Lyssand, J. S., DeFino, M. C., Tang, X. B., Hertz, A. L., Feller, D. B., Wacker, J. L., Adams, M. E., and Hague, C. (2008) Blood pressure is regulated by an R1D-adrenergic receptor/dystrophin signalosome. J. Biol. Chem. 283, 18792-18800.
50. Chen, Z., Hague, C., Hall, R. A., and Minneman, K. P. (2006) Syntrophins regulate R1D-adrenergic receptors through a PDZ domain- mediated interaction. J. Biol. Chem. 281, 12414-12420.
51. Fernandez-Larrea, J., Merlos-Suarez, A., Urena, J. M., Baselga, J., and Arribas, J. (1999) A role for a PDZ protein in the early secretory pathway for the targeting of proTGF-R to the cell surface. Mol. Cell 3, 423-433. (Pubitemid 29292599)
52. Latysheva, N., Muratov, G., Rajesh, S., Padgett, M., Hotchin, N. A., Overduin, M., and Berditchevski, F. (2006) Syntenin-1 is a new component of tetraspanin-enriched microdomains: Mechanisms and consequences of the interaction of syntenin-1 with CD63. Mol. Cell. Biol. 26, 7707-7718.
53. Estrach, S., Legg, J., and Watt, F. M. (2007) Syntenin mediates Delta1-induced cohesiveness of epidermal stem cells in culture. J. Cell Sci. 120, 2944-2952. (Pubitemid 47394268)
54. Chatterjee, N., Stegmuller, J., Schatzle, P., Karram, K., Koroll, M., Werner, H. B., Nave, K. A., and Trotter, J. (2008) Interaction of syntenin-1 and the NG2 proteoglycan in migratory oligodendrocyte precursor cells. J. Biol. Chem. 283, 8310-8317.